We’re excited to share that QAS.AI has received a $1 million Phase II grant from the National Science Foundation (NSF) through the Small Business Technology Transfer (STTR) program.

This award will support the development of our AI-powered platform for real-time, intraoperative prognosis of aneurysm occlusion. The project moves beyond prototype, enabling clinical-grade software development and multi-site evaluation in collaboration with Gates Vascular Institute, Mercy Hospital of Buffalo, and the University of South Florida.

Our goal: empower clinicians with automated occlusion probability insights during neuroendovascular procedures, reducing the need for follow-up interventions and enhancing patient outcomes.

Full article on www.buffalo.edu